Jed Dorsheimer, William Blair analyst, joins 'The Exchange' to discuss Tesla's chip deal with Samsung and what it means for ...

Emerging markets local currency debt posted strong returns in the second quarter, building on momentum from earlier in the ...

William Blair cheers Tesla-Samsung chip deal but keeps TSLA at Hold, citing auto margin woes and valuation concerns.

In addition, The Allstate Corporation (NYSE:ALL) is taking advantage of a far better auto loss environment and employing ...

Fintel reports that on July 25, 2025, William Blair downgraded their outlook for Ameriprise Financial (NYSE:AMP) from ...

As previously reported, William Blair downgraded NeoGenomics (NEO) to Market Perform from Outperform after the company reported Q2 results and cut ...

Vertiv Holdings (NYSE:VRT) on Monday was rated Outperform in new research coverage by analysts at investment firm William ...

William Blair downgraded NeoGenomics (NEO) to Market Perform from Outperform. Published first on TheFly – the ultimate source for real-time, ...

SoFi Technologies Inc. (SOFI) received a bullish endorsement from William Blair on Tuesday, following its second-quarter (Q2) ...

Sarepta Therapeutics shares jumped over 36% on Tuesday after the company said it had received FDA approval to restart ...

In its own communique issued shortly after the FDA’s, Sarepta elaborated on the situation and confirmed a Roche statement to ...

The company didn’t share specific data for the molecule, gefurulimab, but said it hit all endpoints in the Phase III PREVAIL ...